🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Ublituximab (also known as LFB-R603) is a monoclonal antibody that specific...
Status
Completed
Location
Johns Hopkins University School of Medicine
Start Date
2016-01
Trial ID
NCT02276963
Treatments Being Tested
To compare the efficacy of inebilizumab (MEDI-551) versus placebo in reduci...
Status
Completed
Location
Research Site
Start Date
2015-04-01
Trial ID
NCT02200770
Treatments Being Tested
This will be a 12 week, double blind study of omega-3 fatty acids vs. place...
Status
Terminated
Location
Massachusetts General Hospital
Start Date
2007-12
Trial ID
NCT00592683
Treatments Being Tested
Enterobacterieaceae (and specially Escherichia coli) showing resistance due...
Status
Completed
Location
Hospital Mutua de Terrassa
Start Date
2014-07
Trial ID
NCT02142751
Treatments Being Tested
This study is focused on advancing ECT treatment for older adults with depr...
Status
Completed
Location
University of New Mexico
Start Date
2021-03-01
Trial ID
NCT04621786
This Phase 2 study examines the safety, tolerability, and preliminary effic...
Status
Recruiting
Location
University of Kansas, Center for Research
Start Date
2025-10-01
Trial ID
NCT05999240
Treatments Being Tested
This multicenter, single-arm, open-label study will evaluate the long-term ...
Status
Completed
Location
Children's Hospital of Alabama
Start Date
2021-03-02
Trial ID
NCT04660539
Treatments Being Tested
This study is a 6-week open-label clinical trial involving 20 children aged...
Status
Completed
Location
ShanghaiXinhua
Start Date
2022-01-28
Trial ID
NCT05238298
Treatments Being Tested
This phase II trial tests how well retifanlimab with bevacizumab and hypofr...
Status
Recruiting
Location
Mayo Clinic in Arizona
Start Date
2024-10-02
Trial ID
NCT06160206
This phase I trial studies the effects and best dose of ONC206 alone or in ...
Status
Recruiting
Location
University of California, San Francisco
Start Date
2021-08-23
Trial ID
NCT04732065
Treatments Being Tested